Multi-Formula Stripe Coating Process Window: Viscosity, Leveling, and Drying Control for Single-Coat Film Formation

Introduction

For compounded ODFs (Orally Dissolvable Films), multi-formula stripe coating allows for significant efficiency gains and flexibility in dosage combinations. However, it requires precise control over viscosity matching, interface leveling, and drying logic to avoid defects.

Challenges in the Process

• Compound and gradient dosage: Significant viscosity and solid content differences between formulations can amplify interface fluctuations.
• Cross-contamination and boundary clarity: Need to control the interaction between adjacent formulations and the stripe edge.
• Drying and shrinkage: Different volatilization rates cause uneven thickness and content distribution.

Key Process Window Controls

• Viscosity & rheology: Match the coating range for each formulation within the target stripe thickness and edge clarity constraints.
• Leveling & interface: Control the leveling time before coating to avoid stripe diffusion or breakage.
• Drying logic: Use stable hot-air gradients and reasonable airflow paths to balance solvent removal and film surface uniformity.

HUANGHAI’s Solution

• Multi-formula stripe coating technology (patented solution): Industrialized logic to achieve dual-formulation single-coat film formation.
• From R&D to scale-up: Lock in the formulation window and stripe morphology on MJ150-L before transitioning to MJ150 for production.
• Integration with downstream packaging: Reverse-calibrate stripe spacing and shrinkage rates based on cutting dimensions and individual pouch specifications.

*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.

Conclusion

The key to stripe coating is “window alignment.” By closing the loop between formulation rheology, stripe morphology, and drying logic on the same method card, consistency between batches can be maintained during scale-up.

Related Products

• Precision Multi-Formula Coating for ODFs (Patent Solution)
• MJ150-L ODF Film Coating Machine
• Advanced Pharmaceutical Manufacturing

---

Frequently Asked Questions

Q: What is the difference between an ODF film and a transdermal patch?

A: Oral Dissolving Films (ODF) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar solvent-cast film coating processes. Huanghai's MJ150 ODF machine supports both applications on a single platform with approximately 2 working days of changeover time.

Q: What production output can I expect from a Huanghai ODF machine?

A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either machine with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.

Q: What drying technology does Huanghai use for ODF production?

A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform film thickness, reduced edge curl, and better API distribution across the film web. An optional far-infrared heating module adds 20–30% drying efficiency for solvent-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ODF equipment supplier to Sinopharm, Shanghai Pharma, and Fosun Pharma.

Q: What are the GMP requirements for ODF production equipment?

A: ODF manufacturing equipment must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent standards (EU GMP Annex 1, ChGMP) for other markets. Key requirements: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; data integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ODF machines meet these standards—all product contact surfaces use pharmaceutical-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP compliance documentation.

Q: Can Huanghai machines produce stripe-coated or multi-formula ODF films?

A: Yes. Huanghai holds a patent for multi-formula stripe coating (Patent CN117323228A), enabling two different API formulations to be applied side-by-side in a single coating pass. This eliminates the need for multiple coating/drying cycles when producing combination-drug ODF products. Competitors require manual multi-layer coating with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-API ODFs for cardiovascular or CNS indications) where coating efficiency directly impacts production economics.